The Lab of Javad Nazarian, PhD, MS and University Children's Hospital Zurich
In this episode, we’re in Zurich at the University Children’s Hospital to explore the pediatric brain tumor research being led by Dr. Javad Nazarian, whose lab focuses on diffuse midline gliomas (DMGs) and other rare, aggressive pediatric brain tumors. Dr. Nazarian’s work, supported in part by the Glioblastoma Research Organization through Project DeLaRoSa, is aimed at uncovering the biological underpinnings of these tumors to open doors for more targeted and effective treatments. We speak with several members of his research team — including Kamil Wojnicki, PhD, Matteo Bimbati, MSc, and Bettina Kritzer, MSc — about current challenges in the field, the value of interdisciplinary collaboration, and the future of pediatric neuro-oncology. We also hear perspectives from Sandra Fernandes Dias, MD, and Prof. Dr. Michael Grotzer, both of whom work at the University Children’s Hospital, on the clinical realities of treating these diseases and how research and patient care intersect in a hospital setting. This episode offers a behind-the-scenes look at a globally collaborative effort to improve outcomes for children and families facing devastating diagnoses. This episode is intended for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for guidance specific to your health or treatment plan.